Skip to content

Veracyte VCYT Short- and long-term operating lease liabilities

Short- and long-term operating lease liabilities at other companies

Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
-$125K-495%
SolarEdge Technologies logo
SolarEdge TechnologiesSEDG
-$3.81M-13.9%
KEE
Keel Infrastructure Corp. Common StockKEEL
$490K+166%
Repligen logo
RepligenRGEN
-$5.59M-15.7%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
-$593K-106%
Flutter Entertainment logo
Flutter EntertainmentFLUT
-$27M+28.9%

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.29B+10.7%

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's short- and long-term operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's short- and long-term operating lease liabilities?
Veracyte (VCYT) reported short- and long-term operating lease liabilities of -$319K in Q1 2026.
How has Veracyte's short- and long-term operating lease liabilities changed year-over-year?
Veracyte's short- and long-term operating lease liabilities increased by 44.7% year-over-year, from -$577K to -$319K.
What is the long-term trend for Veracyte's short- and long-term operating lease liabilities?
Over 4 years (2021 to 2025), Veracyte's short- and long-term operating lease liabilities has grown at a 8.4% compound annual growth rate (CAGR), from -$1.79M to -$2.48M.